We are live on
!
Find out more
CAG
Crestwood Advisors Group Portfolio holdings
AUM
$5.94B
1-Year Est. Return
18.44%
This Fund
S&P 500
This Quarter
Est. Return
-2.98%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$3.81B
AUM Growth
+$631M
(+20%)
Cap. Flow
+$773M
Cap. Flow
% of AUM
20.27%
Top 10 Holdings %
Top 10 Hldgs %
29.22%
Holding
375
New
120
Increased
150
Reduced
78
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AllianceBernstein
AB
|
+$89.5M |
| 2 |
Roper Technologies
ROP
|
+$37M |
| 3 |
Qualcomm
QCOM
|
+$34.2M |
| 4 |
Mettler-Toledo International
MTD
|
+$30.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$29.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$23.2M |
| 2 |
Bank of America
BAC
|
+$22.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$18.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$5.4M |
| 5 |
MRSH
Marsh
MRSH
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 10.3% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Consumer Staples | 5.78% |
Similar funds
AL
CGPCS
BP
BTCPP
WAM
GFM
VAM
TCM
Crestwood Advisors Group's Q3 2023 Portfolio in Review
As of Q3 2023, Crestwood Advisors Group held 375 positions worth $3.81B, up 20% from $3.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Crestwood Advisors Group deployed $773M of net new capital in Q3 2023, opening 120 new positions and adding to 150 existing holdings. Its largest new stake was AllianceBernstein: 2,817,395 shares worth $85.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ResMed, an estimated $23.2M trimmed.
- Crestwood Advisors Group's largest Q3 2023 buy was AllianceBernstein: 2,817,395 shares worth $85.5M.
- Crestwood Advisors Group added most to Thermo Fisher Scientific in Q3 2023, an estimated $29.1M increase.
- Crestwood Advisors Group's biggest Q3 2023 reduction was ResMed, cutting an estimated $23.2M.
- Crestwood Advisors Group fully exited Focus Financial Partners Inc. Class A in Q3 2023, selling an estimated $1.12M.
- Crestwood Advisors Group's ten largest holdings make up 29% of its $3.81B portfolio in Q3 2023.
- Crestwood Advisors Group opened 120 new positions and closed 10 in Q3 2023.
- Crestwood Advisors Group's portfolio value rose 20% quarter-over-quarter to $3.81B.
Based on Crestwood Advisors Group's 13F filing for Q3 2023, filed 15 Nov 2023.